126 related articles for article (PubMed ID: 4785998)
1. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
[No Abstract] [Full Text] [Related]
2. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Chase RN; Schnur JA; Brody JA; Gordon EK
Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
[No Abstract] [Full Text] [Related]
3. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
Bernheimer H; Birkmayer W; Hornykiewicz O
Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
[No Abstract] [Full Text] [Related]
4. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
Goodwin FK; Post RM
Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
[No Abstract] [Full Text] [Related]
5. Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid.
Bowers MB
Biol Psychiatry; 1974 Aug; 9(1):93-8. PubMed ID: 4457119
[No Abstract] [Full Text] [Related]
6. [Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases].
Fukuda H; Nakamura S; Hara K; Udaka F; Kameyama M
Rinsho Shinkeigaku; 1989 Sep; 29(9):1192-4. PubMed ID: 2480863
[TBL] [Abstract][Full Text] [Related]
7. Toward a biochemical classification of depression.
van Praag HM
Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
[No Abstract] [Full Text] [Related]
8. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
Airaksinen EM; Kauko K
Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
[No Abstract] [Full Text] [Related]
9. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
van Woert MH; Bowers MB
Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
[No Abstract] [Full Text] [Related]
10. [Significance of studying sialic acid in the cerebrospinal fluid and blood serum in childhood schizophrenia].
Zal'tsman EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1521-3. PubMed ID: 5490142
[No Abstract] [Full Text] [Related]
11. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
Bowers MB; Study RE
Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
Olsson R; Roos BE
Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
[No Abstract] [Full Text] [Related]
13. [Neurotransmitters and degenerative diseases in the central nervous system].
Nakamura S
Nihon Ronen Igakkai Zasshi; 1986 Jan; 23(1):11-6. PubMed ID: 2423726
[No Abstract] [Full Text] [Related]
14. [Two-dimensional immuno-electrophoresis of cephalospinal fluid proteins wih a study of the IgG/albumin ratio in psychiatry (author's transl)].
Corti H; Braccini T; Michel AM; Darcourt G; Myquel M
Acta Psychiatr Belg; 1980; 80(4):458-64. PubMed ID: 7282417
[TBL] [Abstract][Full Text] [Related]
15. [2-dimensional immunoelectrophoresis of CSF proteins].
Martin P; Chambon P; Michel AM; Bedoucha P
Rev Neurol (Paris); 1976 Apr; 132(4):241-62. PubMed ID: 935712
[TBL] [Abstract][Full Text] [Related]
16. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
Bowers MB
Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
[No Abstract] [Full Text] [Related]
17. Effect of L-tryptophan on brain serotonin metabolism in depressed patients.
Dunner DL; Goodwin FK
Arch Gen Psychiatry; 1972 Apr; 26(4):364-6. PubMed ID: 4552129
[No Abstract] [Full Text] [Related]
18. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients.
van Praag HM; Korf J
Biol Psychiatry; 1971; 3(2):105-12. PubMed ID: 5089909
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
Chase TN
Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
